Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 12:12:e46883.
doi: 10.2196/46883.

Evaluating a WeChat-Based Health Behavioral Digital Intervention for Patients With Hypertension: Protocol for a Randomized Controlled Trial

Ting Sun  1   2   3 , Huanhuan Zhao  4 , Zenghui Ding  3 , Hui Xie  2 , Linlin Ma  2 , Yu Zhang  2 , Yingying Wang  5 , Yinju Yang  5 , Chunyi Xu  5 , Yining Sun  3 , Xuejie Xu  2 , Zuchang Ma  3
Affiliations

Evaluating a WeChat-Based Health Behavioral Digital Intervention for Patients With Hypertension: Protocol for a Randomized Controlled Trial

Ting Sun et al. JMIR Res Protoc. .

Abstract

Background: Hypertension is the most prevalent chronic condition and a significant risk factor for cardiovascular and kidney diseases. The efficacy of health behavioral interventions in blood pressure (BP) control has been demonstrated by a large and expanding body of literature, with "adherence" playing a crucial role. WeChat is the most common social communication mobile app in China, and it has been shown to be an acceptable delivery platform for delivering health interventions. The WeChat-based health behavioral digital intervention program (WHBDIP) showed high feasibility and efficacy. However, the results regarding BP improvement between the WHBDIP and control groups were inconsistent.

Objective: The objective of this study is to develop a WHBDIP and assess its efficacy in controlling BP and improving adherence among patients with hypertension.

Methods: A 2-arm, parallel-group, and randomized trial design was used. Patients older than 60 years and with hypertension were randomly assigned to either the control group or the experimental group, which received a 12-week intervention. The program, primarily developed based on the Behavior Change Wheel (BCW) theory, offers health education on exercise, diet, BP monitoring, and medicine adherence (MA). It also includes other behavior interventions guided by an intervention manual, incorporating behavior change techniques (BCTs). The primary outcomes encompass BP and adherence indicators, while the secondary outcomes encompass cardiovascular function indicators, body composition indicators, learning performance, satisfaction, and acceptability. The exercise and blood pressure monitoring adherence (BPMA) indicators for the WHBDIP group were assessed weekly via WeChat during the initial 3 months, while other outcome data for both groups will be collected at the baseline assessment phase, 3 months after the intervention, and 1 year after the program.

Results: The trial will assess the efficacy of WHBDIP for patients with hypertension (N=68). The WHBDIP seeks to enhance participants' knowledge of healthy behaviors and assist patients in developing positive health behaviors to improve their health outcomes. Patient recruitment for individuals with hypertension commenced on September 5, 2022, and concluded on September 19, 2022. The 3-month intervention and phased data collection were finalized in January 2023. Data analysis will commence in August 2023, and the final 1-year health outcome results will be collected in September 2023.

Conclusions: A successful WHBDIP will establish the management mode as a feasible approach for hypertension management in the community. Additionally, it will pave the way for the development of related mobile health programs.

Trial registration: Chinese Clinical Trial Registry ChiCTR2200062643; https://tinyurl.com/mwyv67wk.

International registered report identifier (irrid): PRR1-10.2196/46883.

Keywords: adherence; community health; health behavior; hypertension; mobile phone.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Video screenshots.
Figure 2
Figure 2
Figure 2. Study flowchart. BP: blood pressure; BPMA: blood pressure monitoring adherence; DA: dietary adherence; EA: exercise adherence; MA: medicine adherence; PAT: physical activity time; WHBDIP: WeChat-based health behavioral digital intervention program.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. doi: 10.1016/S0140-6736(21)01330-1. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01330... S0140-6736(21)01330-1 - DOI - PMC - PubMed
    1. Hypertension. World Health Organization. [2023-08-16]. https://www.who.int/health-topics/hypertension#tab=tab_1 .
    1. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785–802. doi: 10.1038/s41569-021-00559-8. https://www.nature.com/articles/s41569-021-00559-8 10.1038/s41569-021-00559-8 - DOI - PMC - PubMed
    1. China Cardiovascular Health Disease Report Writing Group Report on cardiovascular health and diseases burden in China: an updated summary of 2020. Chin Circ J. 2021;36(6):521–545. doi: 10.3969/j.issn.1000-3614.2021.06.001. - DOI
    1. Report on Chinese Residents' Chronic Diseases and Nutrition 2015 (1st Edition) Beijing, Beijing, China: People's Medical Publishing House; 2015. National health and family planning commission bureau of disease control and prevention.